European Stroke Organisation expedited recommendation for the use of short-term dual antiplatelet therapy early after minor stroke and high-risk TIA. (June 2021)

• Record Type: Journal Article
• Authors: Dawson, Jesse; Merwick, Áine; Webb, Alastair; Dennis, Martin; Ferrari, Julia; Fonseca, Ana Catarina
• Is Part Of: European stroke journal. Volume 6:Number 2(2021)
• Page Start: CLXXXVII
• Page End: CXCI
• Publication Date: 2021-06
• Subjects: Stroke -- TIA -- antiplatelets; Cerebrovascular disease -- Periodicals; 616.8005
• DOI: 10.1177/23969873211000877
• Languages: English
• ISSNs: 2396-9873

Abstract

Prevention of early recurrent ischaemic stroke remains a priority in people with TIA or ischaemic stroke. A number of trials have recently been completed assessing the efficacy of short-term dual antiplatelet therapy (DAPT) versus single antiplatelet therapy early after minor or moderate stroke or high-risk TIA. We present an Expedited Recommendation for use of dual antiplatelet therapy early after ischaemic stroke and TIA on behalf of the ESO Guideline Board. We make a strong recommendation based on high quality of evidence for use of 21-days of dual antiplatelet therapy with aspirin and clopidogrel in people with a non-cardioembolic minor ischaemic stroke or high-risk TIA in the past 24 hours. We make a weak recommendation based on moderate quality evidence for 30-days of dual antiplatelet therapy with aspirin and ticagrelor in people with non-cardioembolic mild to moderate ischaemic stroke or high-risk TIA in the past 24 hours.